RxSight Inc [RXST] stock prices are up 2.02% to $54.54 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The RXST shares have gain 1.22% over the last week, with a monthly amount glided 4.56%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
RxSight Inc [NASDAQ: RXST] stock has seen the most recent analyst activity on August 20, 2024, when Needham reiterated its Buy rating and also boosted its price target to $66 from $54. Previously, Needham reaffirmed its Buy rating on August 06, 2024, and dropped its price target to $54. On May 07, 2024, BTIG Research reiterated its Buy rating and revised its price target to $72 on the stock. Wells Fargo upgraded its rating to a Overweight and increased its price target to $42 on December 13, 2023. Stifel initiated its recommendation with a Buy and recommended $40 as its price target on December 12, 2023. Morgan Stanley started tracking with a Overweight rating for this stock on December 04, 2023, and assigned it a price target of $36. In a note dated April 13, 2023, Oppenheimer initiated an Outperform rating and provided a target price of $23 on this stock.
The stock price of RxSight Inc [RXST] has been fluctuating between $20.66 and $66.54 over the past year. Currently, Wall Street analysts expect the stock to reach $66.2 within the next 12 months. RxSight Inc [NASDAQ: RXST] shares were valued at $54.54 at the most recent close of the market. An investor can expect a potential return of 21.38% based on the average RXST price forecast.
Analyzing the RXST fundamentals
The RxSight Inc [NASDAQ:RXST] reported sales of 115.18M for trailing twelve months, representing a surge of 67.65%. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -0.34%, Pretax Profit Margin comes in at -0.3%, and Net Profit Margin reading is -0.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.19 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 53.30 points at the first support level, and at 52.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 55.54, and for the 2nd resistance point, it is at 56.53.
Ratios To Look Out For
It’s worth pointing out that RxSight Inc [NASDAQ:RXST]’s Current Ratio is 14.33. On the other hand, the Quick Ratio is 13.34, and the Cash Ratio is 1.25. Considering the valuation of this stock, the price to sales ratio is 18.79, the price to book ratio is 7.85.
Transactions by insiders
Recent insider trading involved Goldshleger Ilya, that happened on Aug 05 ’24 when 9000.0 shares were sold. Officer, ILYA GOLDSHLEGER completed a deal on Aug 05 ’24 to buy 9000.0 shares. Meanwhile, Chief Financial Officer Thunen Shelley B sold 10000.0 shares on Jul 01 ’24.
